Status:
ACTIVE_NOT_RECRUITING
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Carcinoma
Colorectal Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial studies how well self-generated survivorship care plans and telehealth education works in improving knowledge and self-efficacy in cancer survivors living in rural areas. Patients living in...
Detailed Description
OUTLINE: Patients complete a questionnaire at baseline (paper, online, or telephone-based) and have medical records reviewed and are assigned to 1 of 3 cohorts. COHORTS A AND B: Patients are randomi...
Eligibility Criteria
Inclusion
- Cancer survivors who have completed curative therapy within the past 5 years (may still currently be on long-term/targeted non-cytotoxic agent maintenance therapy, e.g., tamoxifen or aromatase inhibitors for breast cancer survivors; androgen deprivation therapy for prostate cancer survivors)
- History of either adult-onset (age \>= 18) lymphoma, breast, colorectal, lung, or prostate cancer
- Able to perform all study requirements, including responding to questionnaires
- Willing to be randomized
- Capable of providing informed consent
- Consent to release oncology and primary care medical records
- English or Spanish speakers
- PRIMARY CARE PROVIDERS: PCPs responsible for delivering primary care to IMPACT study participants will be contacted about participating in the study after participant enrollment into the study.
- ONCOLOGY STAFF: Oncology Staff (Oncologists, Nurse Practitioners, Physician's assistants) will be recruited from sites involved in the IMPACT study
- CLINIC ADMINISTRATORS: Clinic administrators will be recruited from sites involved in the IMPACT study
Exclusion
- Currently on palliative or hospice care, or considering transferring to such care within the next 3 months
- Lacks telephone access
- Lacks mailing address or ability to receive study materials electronically
- Currently being followed in a pediatric clinical setting (either for primary care or for cancer care)
- History of having had \> 1 cancer type diagnosed and treated (exception is for skin cancers treated with surgical excision alone; also, individuals who only have had relapse of their initial cancer remain eligible so long as they have completed curative therapy and meet all other eligibility criteria)
Key Trial Info
Start Date :
February 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2026
Estimated Enrollment :
261 Patients enrolled
Trial Details
Trial ID
NCT04081779
Start Date
February 19 2020
End Date
March 31 2026
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109